痰热清注射液在肝癌术后治疗中的应用

Application of Tanreqing Injection in Post Liuer Cancer Surgery

目的观察肝癌术后应用痰热清注射液的临床疗效及药物不良反应。方法57例肝癌病人分为两组。治疗组30例,男性19例,女性11例,年龄(53±24)岁;对照组27例,男性14例,女性13例,年龄(53±26)岁。两组病人手术方式相同,术后在使用同样药物治疗的基础上,治疗组加用痰热清注射液20 ml静脉滴注,qd。观察两组术后体温变化、咳嗽、咳痰、X光片检查、实验室检查情况。结果治疗第5天,治疗组疗效与对照组有极显著性差异(P<0.01),治疗第10天,治疗组疗效与对照组有显著性差异(P<0.05)。结论肝癌术后应用痰热清注射液临床疗效确切,无严重不良反应发生。

Objective To observe the efficacy and adverse reactions of Tanreqing injection in post liver cancer surgery. Methods 57 patients with liver cancer were divided into two groups. The treatment group of 30 patients （ M19,F11 ; age （ 53 ± s24） a）, the control group of 27 patients （M14, F13;age （53±s26）a）. Two groups had the same way of liver cancer surgery and the similar therapeutic methods besides the treatment group＇received Tanreqing injection 20 ml,iv,gtt, qd. Observe the two groups＇s temperature, cough ,phlegm, experimental phonetics check and so on. Results On the 5th day of therapy the curative effect of treatment group was superior to that of control group（P 〈0.01）, And on the 10th day, the effect was different between the two groups（P 〈 0.05）. Conclusion Tanreqing injection is effective and safe in treatment of liver cancer surgery.